Sarepta therapeutics news today

See also: Sarepta therapeutics news todaySarepta therapeutics stock news

Keywords Suggestions

Sarepta therapeutics news today

( Please select at least 2 keywords )

Related websites

SRPT News Today (Sarepta Therapeutics) MarketBeat

Sarepta Therapeutics (NASDAQ SRPT) News Headlines Today All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source

Marketbeat.com   DA: 18 PA: 25 MOZ Rank: 44

News & Press Releases Sarepta Therapeutics

  • Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress
  • Sarepta Therapeutics to Present at Upcoming Investor Conferences
  • Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program.

Sarepta.com   DA: 15 PA: 9 MOZ Rank: 26

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Get the latest Sarepta Therapeutics, Inc
  • (SRPT) stock news and headlines to help you in your trading and investing decisions.

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 37

SRPT Stock Price Sarepta Therapeutics Inc. Stock …

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 44

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Get the latest news and real-time alerts from Sarepta Therapeutics, Inc

Seekingalpha.com   DA: 16 PA: 17 MOZ Rank: 38

SRPT Stock News SAREPTA THERAPEUTICS Stock …

SRPT: Get the latest Sarepta Therapeutics stock price and detailed information including SRPT news, historical charts and realtime prices.

Markets.businessinsider.com   DA: 27 PA: 18 MOZ Rank: 51

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, …

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 35

Sarepta Therapeutics Biopharmaceutical Company for …

  • Today, we are doing just that in Duchenne muscular dystrophy, in six forms of limb-girdle muscular dystrophy, in Charcot-Marie-Tooth disease, and in Mucopolysaccharidosis type IIIA (MPS IIIA), among others
  • Sarepta will always follow the science and continuously …

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 38

Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) …

  • Find the latest news headlines from Sarepta Therapeutics, Inc
  • Common Stock (DE) (SRPT) at Nasdaq.com.

Nasdaq.com   DA: 14 PA: 43 MOZ Rank: 66

Do Analysts Expect Sarepta Therapeutics Inc (SRPT) …

  • What's Happening With Sarepta Therapeutics Inc Stock Today? Sarepta Therapeutics Inc (SRPT) stock is down -1.25% while the S&P 500 has gained 0.99% as of 12:07 PM on Monday, Aug 23
  • SRPT has fallen -$0.94 from the previous closing price of $75.31 on volume of 477,592 shares.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 85

-$2.03 EPS Expected for Sarepta Therapeutics, Inc. …

  • Sarepta Therapeutics (NASDAQ:SRPT) last released its quarterly earnings data on Wednesday, August 4th
  • The biotechnology company reported ($1.02) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($1.29) by $0.27
  • Sarepta Therapeutics had a negative return on equity of 94.90% and a negative net margin of 105.73%.

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 79

SRPT Sarepta Therapeutics Inc. Stock Overview (U.S

  • Complete Sarepta Therapeutics Inc
  • View real-time SRPT stock price and news, along with industry-best analysis.

Barrons.com   DA: 15 PA: 24 MOZ Rank: 51

SRPT Stock Forecast, Price & News (Sarepta …

  • 20 brokers have issued twelve-month target prices for Sarepta Therapeutics' shares
  • Their forecasts range from $75.00 to $215.00
  • On average, they expect Sarepta Therapeutics' share price to reach $132.65 in the next twelve months
  • This suggests a possible upside of 62.0% from the stock's current price
  • View analysts' price targets for Sarepta

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 51

SRPT Sarepta Therapeutics Inc. — Stock Price and

  • NASDAQ Updated Sep 22, 2021 10:48 PM SRPT 87.47 0.15 (0.17%)

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 40

Why Sarepta Therapeutics Stock Is Crashing Today …

  • Shares of Sarepta Therapeutics ( NASDAQ:SRPT) were crashing 50.7% as of 11:11 a.m
  • The huge decline came after the biotech announced top-line results late on …

Fool.com   DA: 12 PA: 50 MOZ Rank: 77

Sarepta Therapeutics (SRPT) Stock Price, News & Info …

Why Sarepta Therapeutics Stock Is Crashing Today Keith Speights | Jan 8, 2021 The biotech announced disappointing results from a clinical study of its lead gene-therapy candidate.

Fool.com   DA: 12 PA: 40 MOZ Rank: 68

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • News Sarepta Therapeutics Inc.SRPT
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings

Wsj.com   DA: 11 PA: 24 MOZ Rank: 52

Sarepta Therapeutics Stock Is Estimated To Be Possible

  • Sarepta Therapeutics has been profitable 0 over the past 10 years
  • Over the past twelve months, the company had a revenue of $573.4 million and loss of $8.94 a share.

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 85

SRPT -- Is Its Stock Price A Worthy Investment

  • Sarepta Therapeutics to Present at Upcoming Investor Conferences
  • 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences: Morgan Stanley Global Healthcare Conference …

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 44

Investor Relations Sarepta Therapeutics, Inc.

  • FRONT >> News > View All Archived Press Releases Events & Presentations
  • Date Title; 09/27/21 at 1:20 PM EDT Sarepta Therapeutics at the Cantor Fitzgerald Virtual Global Healthcare Conference
  • 09/20 - 09/24/21 2021 World Muscle Society Virtual Congress

Investorrelations.sarepta.com   DA: 29 PA: 29 MOZ Rank: 78

Should You Buy Sarepta Therapeutics Inc (SRPT) Stock …

  • Sarepta Therapeutics Inc (SRPT) stock is trading at $79.32 as of 11:49 AM on Wednesday, Aug 25, a gain of $1.97, or 2.55% from the previous closing price of $77.35
  • The stock has traded between $76.38 and $79.79 so far today

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 96

Sarepta Therapeutics, Inc.

  • ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Sarepta Therapeutics, Inc

Thestreet.com   DA: 17 PA: 11 MOZ Rank: 50

Sarepta Therapeutics Announces FDA Approval of

  • 25, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S
  • Food and Drug Administration (FDA) has approved AMONDYS 45 (casimersen).

Apnews.com   DA: 10 PA: 50 MOZ Rank: 83

SRPT Stock Alert: Why Sarepta Therapeutics Stock Is

SRPT Stock Alert: Why Sarepta Therapeutics Stock Is Plunging Today January 8, 2021 By Nick Clarkson , Web Editor Jan 8, 2021, 11:26 am EDT January 8, 2021

Investorplace.com   DA: 17 PA: 50 MOZ Rank: 91

SRPT: Sarepta Therapeutics Inc

Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 49

After A 50% Fall Sarepta Therapeutics Stock Now Looks

  • Sarepta Therapeutics stock, is a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases

Forbes.com   DA: 14 PA: 50 MOZ Rank: 90

Why Sarepta Therapeutics Stock Is Crashing Today

  • Shares of Sarepta Therapeutics (NASDAQ: SRPT) were crashing 50.7% as of 11:11 a.m
  • The huge decline came after the biotech announced top-line results late on …

Msn.com   DA: 11 PA: 50 MOZ Rank: 88

SAREPTA THERAPEUTICS Value.Today

  • (Net Loss) -554 Million USD for Year ending December-2020.

Value.today   DA: 15 PA: 29 MOZ Rank: 72

Sarepta Therapeutics Stock Price Today (NASDAQ: …

  • Sarepta Therapeutics stock was originally listed at a price of $41.25 in Dec 31, 1997
  • If you had invested in Sarepta Therapeutics stock at $41.25, your return over the last 23 years would have been 112.41%, for an annualized return of 3.33%.

Wallstreetzen.com   DA: 21 PA: 22 MOZ Rank: 72

Analysts Say Sarepta Therapeutics Inc. Can Reach …

  • (NASDAQ:SRPT)’s traded shares stood at 0.52 million during the last session, with the company’s beta value hitting 1.36
  • At the close of trading, the stock’s price was $78.69, to imply an increase of 0.46% or $0.36 in intraday trading
  • The SRPT share’s 52-week high

Marketingsentinel.com   DA: 21 PA: 50 MOZ Rank: 20

August 27th Options Now Available For Sarepta …

  • Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the August 27th expiration
  • At Stock Options Channel, our …

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 95

Sarepta Craters, Cutting Market Value in Half on …

Shares in Sarepta Therapeutics Inc., a biotech focused on rare diseases, lost 50% of their value on Friday and erased $6.75 billion in the company’s market capitalization, after a key study on a

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 99

Sarepta Therapeutics to Present at Upcoming Investor

  • Sarepta Therapeutics to Present at Upcoming Investor Conferences 09/07/21 4:30 PM EDT CAMBRIDGE, Mass., Sept
  • 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 17

Sarepta Therapeutics, Inc.

  • SRPT investment & stock information
  • Get the latest Sarepta Therapeutics, Inc
  • SRPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Zacks.com   DA: 13 PA: 17 MOZ Rank: 64

Sarepta Therapeutics (SRPT) Stock Price, Quote & …

  • CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will part

Stockanalysis.com   DA: 17 PA: 13 MOZ Rank: 65

SRPT Stock Quote of Sarepta Therapeutics

  • Apple's health initiative can't keep key people and Sarepta Therapeutics' CLR are a couple more top news items about the stock market today

Investorplace.com   DA: 17 PA: 31 MOZ Rank: 84

SRPT Stock Price Quote & News

  • You can buy and sell Sarepta Therapeutics (SRPT) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news
  • Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.

Robinhood.com   DA: 13 PA: 12 MOZ Rank: 62

Sarepta Therapeutics to Present at Upcoming Investor

  • Do NOT follow this link! September 7, 2021 - 4:30 pm
  • 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 12

SRPT Stock Pops After Gene Therapy Beats Sarepta's …

  • SRPT Stock Rises On Gene Therapy Test
  • Sarepta's gene therapy aims to replace the gene that codes for the beta-sarcoglycan protein
  • After two months, the high-dose group showed an average 72.3% of

Investors.com   DA: 17 PA: 50 MOZ Rank: 11

Sarepta Tanks On Likely 2-Year Delay For Muscular

  • Sarepta Therapeutics' gene therapy targeting muscular dystrophy could be delayed for two years, an analyst said Friday as SRPT stock crashed on mixed test results.

Investors.com   DA: 17 PA: 50 MOZ Rank: 10

Sarepta Therapeutics Announces Recipients of Route …

  • Do NOT follow this link! September 7, 2021 - 8:30 am
  • 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced fifteen recipients of Route 79, The Duchenne Scholarship Program.

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 9

Sarepta Therapeutics Inc Stock Quote: SRPT Stock …

SRPT, Sarepta Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

Research.investors.com   DA: 22 PA: 50 MOZ Rank: 8

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Giasuhanoi.com1 year, 166 days leftTurnCommerce, Inc. DBA NameBright.comAmazon Technologies Inc.
Arroyoroble.com2 years, 288 days leftNetwork Solutions, LLCThe Endurance International Group, Inc.
Kruispad.net 212 days leftTucows Domains Inc.Domain Name Services
Andersonmaterials.com1 year, 8 days leftNetwork Solutions, LLCThe Endurance International Group, Inc.
Barbarawitkowska.com 311 days leftSav.com, LLC - 8Bodis, LLC
Mymarketingbench.com2 years, 171 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Mythicmobs.net 229 days leftNameCheap, Inc.Cloudflare, Inc.
Rodantech.com1 year, 45 days leftKey-Systems GmbHDomain Name Services
Wickedlocal.com 34 days leftMarkMonitor Inc.Fastly
Palfinger.com 312 days leftAscio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USADomain Name Services

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]